Literature DB >> 18003972

Multiple alloantibodies after transfusion in an infant treated with infliximab.

Lisa N Tyler, Terry O Harville, Douglas P Blackall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003972     DOI: 10.1056/NEJMc070741

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

Review 2.  The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders.

Authors:  Eric A Gehrie; Christopher A Tormey
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

3.  Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients.

Authors:  Carla Luana Dinardo; Gláucia Munemasa Ito; Luciana Ribeiro Sampaio; Alfredo Mendrone Júnior
Journal:  Rev Bras Hematol Hemoter       Date:  2013

4.  Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion.

Authors:  Seema R Patel; David R Gibb; Kathryn Girard-Pierce; Xiaoxi Zhou; Lilian Cataldi Rodrigues; Connie M Arthur; Ashley L Bennett; Ryan P Jajosky; Megan Fuller; Cheryl L Maier; Patricia E Zerra; Satheesh Chonat; Nicole H Smith; Christopher A Tormey; Jeanne E Hendrickson; Sean R Stowell
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.